B-Cell Leukemia Global Clinical Trials Review, H1, 2016
SKU ID :GD-10191668 | Published Date: 31-May-2016 | No. of pages: 454Description
TOC
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of B-Cell Leukemia to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of B-Cell Leukemia to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in B-Cell Leukemia Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 451
Abbreviations 451
Definitions 451
Research Methodology 452
Secondary Research 452
About GlobalData 453
Contact Us 453
Disclaimer 453
Source 454
Tables & Figures
List of Tables
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2016* 6
B-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
B-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
B-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
B-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
B-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
B-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of B-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of B-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2016* 20
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
B-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
B-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
B-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
B-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
B-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
B-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
List of Figures
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
B-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
B-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
B-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
B-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
B-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
B-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of B-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
B-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of B-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
B-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
B-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
B-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
B-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
B-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
B-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
B-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
B-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
B-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 452
Companies
F. Hoffmann-La Roche Ltd.
Celgene Corporation
Novartis AG
AbbVie Inc.
AstraZeneca Plc
GlaxoSmithKline Plc
Sanofi
Gilead Sciences, Inc.
Merck & Co., Inc.
Bayer AG
- PRICE
-
$2500$7500